{"database": "lobbying", "table": "lobbying_activities", "rows": [[2102380, "f7fe3268-90d1-4bcf-8988-0e95ba7c232f", "Q1", "JEFFREY J. KIMBELL & ASSOCIATES, INC.", 46038, "SANTHERA PHARMACEUTICALS (USA), INC.", 2018, "first_quarter", "MED", "Issues related to development of treatments for rare diseases.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2018-04-06T09:50:16.300000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2102380"], "units": {}, "query_ms": 0.4846399970119819, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}